Name: VERA Balance Sheet - Vera Therapeutics Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

VERA - Vera Therapeutics, Inc.

USD | NASDAQ | Healthcare

VERA Balance Sheet - Vera Therapeutics Assets & Debt | Ledgeburg

(in millions of USD)	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Cash And Short Term Investments
Cash And Equivalents	354.7	92.6	45.7	43.5	79.7	53.7	-
Restricted Cash	-	-	-	-	0.0	0.1	-
Short Term Investments	359.9	548.2	115.0	71.2	0.0	-	-
Cash And Short Term Investments	714.6	640.9	160.7	114.7	79.7	53.7	-
Receivables
Accounts Receivable	-	-	-	-	-	-	-
Current Assets
Inventory	-	-	-	-	-	-	-
Prepaid Expenses	14.3	10.4	11.3	11.0	2.9	0.6	-
Non-Current Assets
Property, Plant & Equipment Gross	-	-	-	-	-	-	-
Accumulated Depreciation	-	-	-	-	-	-
Current Liabilities
Accounts Payable	21.9	7.7	11.1	12.0	1.4	0.9	-
Short Term Debt	-	-	-	-	-	-	-
Non-Current Liabilities
Long Term Debt	74.8	50.7	49.9	24.8	4.9	0.0	-
Operating Lease Liabilities Non-Current	1.9	2.5	1.4	3.8	0.0	-
Common Equity
Common Stock	0.1	0.1	0.0	0.0	-	-	-
Additional Paid In Capital	-	-	-	-	-	-	-
Supplementary Data
Total Debt	74.8	50.7	49.9	24.8	4.9	0.0	-
Net debt	(639.8)	(590.2)	(110.8)	(89.8)	(74.8)	(53.7)	-

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19
Cash And Short Term Investments
Cash And Equivalents	114.4	354.7	57.8	49.1	55.1	92.6	27.3	25.1	69.1	45.7	27.4	33.9	137.4	43.5	30.5

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Current Assets
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid Expenses	19.0	14.3	13.9	14.5	16.2	10.4	10.8	10.4	12.7	11.3	11.7	9.6	7.3	11.0	10.6	10.4	6.8	2.9
Other Current Assets	2.5	2.6	1.1	1.6	1.8	1.1	1.1	0.4	0.6	0.9	1.9	1.4	0.9	0.8	0.8	0.8	0.8
Assets Held For Sale	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Assets	615.8	728.9	511.3	571.4	606.1	651.2	364.1	394.7	416.4	172.0	171.6	190.6	204.4	125.7	125.0	142.3

Current Liabilities
Accounts Payable	13.9	21.9	18.0	13.2	9.3	7.7	4.6	4.7	5.2	11.1	12.3	13.3	5.3	12.0	7.0	7.1	7.3	1.4	1.0	1.7	1.4	0.9	-	-	-	-
Short Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Current	-	-	0.5	0.9	1.2	1.5	1.9	2.1	2.3	2.4	2.5	2.6	2.6	2.6	2.7	2.5
Accrued Expenses	31.2	31.6	23.5	19.5	11.4	16.2	20.0	11.6	7.1	8.7	9.8	11.0	15.6	11.0	6.2	7.7	10.2	5.9
Other Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Liabilities	45.1	53.5	41.9	33.6	21.9	25.4	26.5	18.4	14.5	22.3	24.6	26.8	23.5	25.6	15.9

Non-Current Liabilities
Long Term Debt	75.0	74.8	74.6	74.5	50.9	50.7	50.5	50.3	50.1	49.9	25.0	25.0	24.9	24.8	5.0	5.0	4.9	4.9	-	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	-	-	2.1	2.2	2.4	2.5	2.6	0.5	0.9	1.4	2.0	2.6	3.2	3.8	4.5	4.8
Deferred Revenue Non-Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Tax Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pension Obligations	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Liabilities	1.9	1.9	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non-Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	122.0	130.2	118.6	110.3	75.2	78.5	79.5	69.4	65.8	73.9	51.9	54.7	51.9	54.5	25.7	27.3

Common Equity
Common Stock	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Additional Paid In Capital	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	(881.9)	(760.9)	(669.8)	(589.5)	(512.9)	(461.3)	(417.8)	(371.2)	(337.5)	(309.1)	(283.4)	(263.3)	(243.2)	(213.1)	(180.7)	(156.0)	(141.1)
Accumulated Other Comprehensive Income	(0.2)	0.8	0.9	0.5	0.7	0.4	1.0	(0.5)	(0.2)	0.3	(0.1)	(0.1)	(0.0)	(0.2)	(0.3)	(0.2)
Treasury Stock	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Stockholders Equity	499.7	604.5	398.9	468.3	535.0	577.2	289.1	327.9	353.5	101.7	123.7	140.5	157.7	76.9	105.7	121.5	134.4
Total Equity	499.7	604.5	398.9	468.3	535.0	577.2	289.1	327.9	353.5	101.7	123.7	140.5	157.7	76.9	105.7	121.5	134.4	69.6

Supplementary Data
Total Debt	75.0	74.8	74.6	74.5	50.9	50.7	50.5	50.3	50.1	49.9	25.0	25.0	24.9	24.8	5.0	5.0	4.9	4.9	-	-	-	-	-	-	-	-
Net debt	(521.7)	(639.8)	(422.7)	(482.4)	(538.9)	(590.2)	(302.8)	(334.1)	(353.6)	(110.8)	(134.9)	(156.1)	(172.3)	(89.8)	(109.5)	(127.0)	(146.0)	(74.8)
Working Capital	570.7	675.4	469.4	537.8	584.2	625.8	337.7	376.3	401.8	149.7	147.0	163.8	180.9	100.1	109.1	125.1	137.8	74.8
Book Value	499.7	604.5	398.9	468.3	535.0	577.2	289.1	327.9	353.5	101.7	123.7	140.5	157.7	76.9	105.7	121.5	134.4	69.6
Tangible Book Value	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-